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Abstract
Objectives: Lower socioeconomic status (SES) is consistently associated with poor health, yet little is known about the
biological mechanisms underlying this inequality. In children, we examined the impact of early-life SES trajectories on the
intensity of global innate immune activation, recognizing that excessive activation can be a precursor to inflammation and
chronic disease.
Methods: Stimulated interleukin-6 production, a measure of immune responsiveness, was analyzed ex vivo for 267 Canadian
schoolchildren from a 1995 birth cohort in Manitoba, Canada. Childhood SES trajectories were determined from parent-
reported housing data using a longitudinal latent-class modeling technique. Multivariate regression was conducted with
adjustment for potential confounders.
Results: SES was inversely associated with innate immune responsiveness (p=0.003), with persistently low-SES children
exhibiting responses more than twice as intense as their high-SES counterparts. Despite initially lower SES, responses from
children experiencing increasing SES trajectories throughout childhood were indistinguishable from high-SES children. Low-
SES effects were strongest among overweight children (p,0.01). Independent of SES trajectories, immune responsiveness
was increased in First Nations children (p,0.05) and urban children with atopic asthma (p,0.01).
Conclusions: These results implicate differential immune activation in the association between SES and clinical outcomes,
and broadly imply that SES interventions during childhood could limit or reverse the damaging biological effects of
exposure to poverty during the preschool years.
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Introduction
Social environments in early life are known to affect the course
of human development. Socioeconomic status (SES) differences
originating in childhood can influence susceptibility to cardiovas-
cular disease, diabetes, asthma, and obesity in later life [1,2].
Lower SES has consistently been associated with greater risk of
disease, more rapid progression, and decreased survival [3];
however, since most studies focus on adult outcomes, it is unclear
when SES-related health disparities emerge during the life course.
In addition, despite longstanding and worldwide recognition of
social gradients in health, the biological mechanisms underlying
these inequalities remain poorly understood.
SES is a complex and dynamic measure reflecting gradients of
exposure to various environmental and lifestyle factors, such as
neighbourhood crime, air pollution, family stress, and access to
healthcare and proper nutrition. As a multi-dimensional construct,
SES can be challenging to quantify for research purposes.
Commonly used SES indicators vary from ‘‘wealth’’ measures
such as income and savings, to ‘‘prestige’’ measures such as
occupation or education [1]. SES can also be conceptualized at
the individual, family or neighbourhood level, with each sphere
having somewhat distinct relationships with health. While the
great majority of studies employ static measures of SES, reflecting
a single point in time, there is growing interest in the cumulative
effect of SES beginning in early life [1]. Such dynamic,
‘‘trajectory’’ measures provide invaluable information [4] but are
uncommon because data are often lacking to implement them.
One mechanism by which SES may ultimately exert its effects
on health is via differential activation of the immune system,
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Inflammation is a key pathway in many diseases including
rheumatoid arthritis, cardiovascular and neurodegenerative dis-
eases, asthma, diabetes, obesity and cancer [5,6]. Extensive cross
sectional studies link low SES to increased systemic immune
activation, inflammation, poor health outcomes, and reduced
activity of the anti-inflammatory hormone cortisol [7–9]. While
the causal role of immune activation remains controversial [10–
12], SES-related differences are documented for pro-inflammatory
gene expression [13,14] and diverse circulating inflammatory
biomarkers such as C-reactive protein and interleukin-6 (IL-6)
[15–19]. IL-6 levels are widely used as a surrogate marker of
chronic inflammation; however, this molecule can function as a
pro-inflammatory or anti-inflammatory cytokine depending on the
physiological context. IL-6 also exhibits highly pleiotropic
functions in immune regulation, inflammation and oncogenesis
among others. Thus, tagging IL-6 as a biomarker of inflammation
risks over-simplification of a molecule exhibiting a broad range of
activities depending on the stimulus and outcome examined [20–
22]. Here, we assess IL-6 as a global indicator of the intensity of
innate immune capacity or activation, rather than attributing a
single specific quality to the response.
It is important to note that many circulating biomarkers,
including plasma IL-6 levels, fluctuate substantially according to
meal consumption, time of day, exercise and the menstrual cycle
[23]. By contrast, we find that IL-6 responses elicited directly ex
vivo by environmental stimuli, while considerably more laborious
than plasma analyses, can be standardized to yield reliable
measures of innate immune capacity in any given individual [24].
Moreover, IL-6 originates in vivo from multiple sources beyond
immune cells, including adipose tissue, muscle and the central
nervous system among others [25]. Consequently, circulating IL-6
does not necessarily reflect immune activation, but there is no such
ambiguity with an ex vivo stimulated measure.
Thus, previous studies seeking to identify associations between
SES, immune biomarkers and clinical outcomes have been
challenged to account for changes in SES, have been primarily
conducted in adults, and have mainly analyzed circulating
biomarkers susceptible to considerable experimental challenges.
In this study, undertaken with an appreciation for SES as a multi-
dimensional construct, we aimed to determine if associations were
detectable between proxy dynamic measures of SES throughout
childhood, and global innate immune responsiveness at school age.
Methods
Ethics Statement
The study was approved by the University of Manitoba Health
Research Ethics Board and Health Information Privacy Commit-
tee. Parents also provided written informed consent.
Study population
The study population comprised 267 children from the nested
case-control arm of the Study of Asthma, Genes and Environment
(SAGE) birth cohort in Manitoba, Canada. Full details of the study
design are reported elsewhere [26]. Based on estimates from our
previous research [24] (mean log-normalized IL-6 response, in pg/
mL, upon 0.05 ng/mL LPS stimulation=7.0; standard devia-
tion=0.5) we calculated that the required sample size to detect a
50% change in absolute IL-6 production, with 5% error and 80%
power, is 24 subjects per SES trajectory group.
Children were recruited at mean age 9 (range 8–10) after parent
response to a mailed survey on child health; they were examined
by a pediatric allergist to confirm asthma status, and atopy was
determined by skin-prick testing for common allergens [26].
Overweight was defined as body mass index $85th percentile
according to age and sex-specific growth charts [27]. Maternal
asthma was defined as report of: asthma or use of asthma
medications in the last 12 months, or physician-diagnosed asthma
with onset after age 5. Maternal allergy was defined as report of
hay fever or food allergy. Data on family and environmental
factors were obtained from the same questionnaire, including:
family size (number of people living in the family home, including
study child, at age 9), number and age of siblings, residence
location (urban or rural, based on home postal code), household
income (reported in several categories), relocation since birth (ever
or never), First Nations ethnicity (FN; also known as Canadian
aboriginal), gestational age, birth weight, breastfeeding (defined as
exclusive breastfeeding for at least 3 months), and maternal
smoking (during pregnancy and/or the first year after birth).
Perinatal maternal distress (present or absent) was defined based
on mother’s response to a question on whether she felt down,
depressed or hopeless during the year after delivery, as previously
described [28]. Small-for-gestational-age (SGA) was defined as
,10
th percentile according to sex-specific percentiles for birth
weight and gestational age in Canadian children [29]. Child use of
anti-inflammatory medications (such as beclomethasone, Pulmi-
cort, or Flovent) in the preceding 12 months was also reported by
parents.
Due to limited resources for processing fresh blood, not all case-
control children could be assessed for LPS-stimulated IL-6
production. Nevertheless, a large subgroup was selected
(N=409), including 164 healthy children without asthma or
allergies. Analyses were conducted on the 267 children with SES
trajectory data (see below). Children with known versus unknown
SES trajectories did not differ on current household income, IL-6
production, family size, gender, atopy or asthma (Table 1).
SES trajectories
Using the method recently reported by Marin et al. [30],
childhood SES trajectories were derived from questionnaire data
where parents reported the number of bedrooms in the family
home for each year of the child’s life. Number of bedrooms was
used as a proxy for SES because housing is more accurately
recalled compared to other measures such as income [31], and is a
more dynamic measure compared to indicators such as parent
education. Thus, since longitudinal income data were not collected
prospectively and cannot be accurately recalled retrospectively,
number of bedrooms was selected as a reliable and dynamic
measure which could be used to study SES trajectories throughout
childhood. Most families in our study (55%) had moved since the
child’s birth, allowing us to capture changes in housing over time.
Marin et al. [30] established that ‘‘number of bedrooms’’ is a
better indicator of family wealth than ‘‘number of bedrooms per
person’’, a measure of crowding best used to distinguish
individuals at the low end of the SES spectrum. Nevertheless, to
account for family size as a potential confounder, we adjusted all
statistical models for family size (number of people living in the
family home) at age 9.
A semiparametric, group-based modeling strategy (the SAS
‘‘TRAJ’’ procedure) was used to separate individual children into
trajectory groups [32], based on changes to the number of
bedrooms in the family home throughout childhood. Bayes’
theorem was coupled with TRAJ to assign children to the SES/
bedroom trajectory group to which they had the highest
probability of belonging. The desired number of trajectories
(beginning with a single trajectory and increasing one at a time)
was specified before running each model. The Bayesian Informa-
SES Trajectories and Innate Immune Responsiveness
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trajectories, with the goal of identifying the fewest number of
trajectories that best fit the data [32,33].
Cell culture and IL-6 assay
Whole blood was drawn during a daytime clinic visit at mean
age 9. The time was recorded, and processing was initiated within
3 hours. All subjects reported being free of symptomatic respira-
tory infections in the preceding two months. Peripheral blood
mononuclear cells (PBMC) were isolated from whole blood by
standard techniques and used immediately for culture in triplicate.
Preliminary studies were performed to establish optimal culture
conditions, cell density and time of harvest (not shown). We
previously demonstrated the importance of utilizing environmen-
tal immune stimuli at physiologic levels [24]; therefore, PBMC
were stimulated with 0.05 ng/ml bacterial endotoxin (lipopoly-
saccharide, LPS) (Sigma). Supernatants were harvested after
24 hours and IL-6 production was quantified by ELISA
(Biolegend). Each sample was evaluated in at least 2 assays, with
the IL-6 concentration calculated from a minimum of 3 points
falling on the linear portion of standardized titration curves.
Standard errors typically ranged from 3–10% per sample. The
time of blood draw did not influence IL-6 production (r=20.02,
p=0.82).
Statistical analysis
Statistical analyses were conducted using SAS 9.2 statistical
software package and GraphPad Prism 5 software. IL-6 values
were normalized by log-transformation and compared by t-test,
univariate linear regression, or ANOVA with Bonferroni’s post-
hoc test for multiple comparisons. Distribution among SES
trajectory groups was compared by chi-squared test.
Multiple linear regression was conducted to adjust associations
between SES trajectories and IL-6 for the following covariates,
based on established associations with inflammation or IL-6
production: residence location [34,35], child atopy/asthma
phenotype [36–38], maternal history of allergy/asthma [39,40],
overweight [41], gender [42], and FN ethnicity [43]. Early life
factors known to influence inflammation or IL6 were tested in
secondary analyses; these included: maternal distress [44],
maternal smoking [45], mother’s parity [46], exclusive breast
feeding .3 months [47], birth weight [48], and relocation since
birth [49]. All models were adjusted for family size at age 9.
Interaction terms were tested using a relaxed type 1 error rate of
10%, a common approach in epidemiological studies used to
increase power for detecting effect modification [50]. Results are
reported as relative differences (response ratios) and associated p-
values.
Results
Study population
The 267 study participants (55% male; mean age 9) were
distributed between urban (56%) and rural (44%) residence
locations, and included 45 (16.9%) First Nations (FN) children
(Table 2). Similar to the Manitoba population, the remaining
children were predominantly Caucasian (76.0%). By design, the
study over-sampled children with asthma; there were 58 children
with atopic asthma, 34 with non-atopic asthma, 64 with atopy
only, and 111 healthy children. Twenty-six percent of children
were overweight.
Identification of SES trajectory groups
SES trajectories were derived from parent-reported housing
data. As described in ‘‘Methods’’, individual children were
assigned to trajectory groups using a group-based statistical
modeling strategy. The Bayesian Information Criterion (BIC)
was 26096 for 3 groups, 25626 for 4 groups, and 25452 for 5
groups, demonstrating increasingly better fit with the addition of
each trajectory group. To prevent small group size, we did not
exceed a 5-group model. As shown in Figure 1, four of the five
identified trajectories indicated stable SES throughout childhood
(designated low, mid, mid-high, or high). The fifth ‘‘increasing
SES’’ trajectory, where SES until age 4 was below the mid-SES
group but improved to exceed the mid-high-SES group by age 9,
represented a significant increase in SES from birth (p,0.001).
The persistent mid-SES group was used as the reference group as
it comprised the largest proportion of children (N=119, 44.6%),
thus representing the ‘‘average’’ childhood SES trajectory in this
population-based cohort. The remaining children were classified
as follows: 33 low-SES, 26 increasing-SES, 71 mid-high-SES, and
18 high-SES.
Impact of SES trajectories on immune responsiveness
IL-6 responses were quantified in freshly isolated immune cells
following stimulation with LPS, a widely-encountered environ-
Table 1. Characteristics of children with known versus
unknown SES trajectories.
SES Trajectory
unknown known
n=139 n=267 p
3
Gender (% male) 54.0 55.4 0.77
First Nations Ethnicity (% yes) 35.3 16.9 0.001
Residence (% rural) 58.3 43.8 0.01
Child Overweight (% yes) 41.0 25.8 0.001
Child Atopy/Asthma (%)
Atopic Asthma 20.1 21.7 0.60
Atopy, no Asthma 25.2 24.0
Non-atopic Asthma 17.3 12.7
Healthy 37.4 41.6
Anti-Inflammatory Medications (%yes) 26.6 31.5 0.31
Mother Allergy/Asthma (% yes) 48.9 63.3 0.01
Annual Family Income (%)
,$50,000 32.4 24.5 0.27
,$80,000 34.3 35.7
$$80,000 33.3 39.8
Older Maternal Siblings (% yes) 54.0 58.0 0.45
Birth Weight (% Preterm or SGA) 21.1 18.3 0.52
Exclusive Breastfeeding
1 (% yes) 40.0 54.7 0.01
Mother Smoked
2 (% yes) 30.2 19.1 0.01
Maternal Distress (% yes) 19.6 22.1 0.60
Family Size at age 9 (mean) 4.7 4.6 0.29
IL-6 (geometric mean, pg/mL) 1138 1097 0.74
IL-6, interleukin-6; SES, socioeconomic status; SGA, small for gestational age.
IL-6 production induced by LPS treatment of PBMC.
1Exclusive breastfeeding $3 months;
2Mother smoked during pregnancy and/or first year after birth;
3Comparisons
by chi-squared test (categorical variables) or t-test (continuous variables).
doi:10.1371/journal.pone.0038669.t001
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from 10 to 10,000 pg/ml (Figure 2) with individual variation
,10%, indicating the stability of this measure. A clear trend of
elevated immune activation was found with decreasing SES (p for
trend=0.003). Persistent low-SES was associated with the highest
IL-6 responses (geometric mean, 1994 pg/ml), while persistent
Table 2. Population characteristics and distribution of potential confounding factors in relation to innate immune responsiveness
(stimulated IL-6 response) at age 9 and childhood SES trajectories.
IL-6 Response (pg/ml) Childhood SES Trajectory Distribution (%)
N (%) Geo. Mean p
4 Low Mid Mid-High High Incre-asing p
6
Overall 267 1097 12.4 44.6 26.6 6.7 9.7
Gender Female 119 (44.6) 1087 0.92 7.6 47.9 27.7 5.9 10.9 0.27
Male 148 (55.4) 1103 16.2 41.9 25.7 7.4 8.8
First Nations Ethnicity No 222 (83.2) 1054 0.14 10.4 46.9 26.6 6.3 9.9 0.18
Yes 45 (16.9) 1331 22.2 33.3 26.7 8.9 8.9
Residence Urban 150 (56.2) 1258 0.03* 14.0 46.0 26.0 6.7 7.3 0.56
Rural 117 (43.8) 920 10.3 42.7 27.4 6.8 12.8
Relocation Since Birth No 120 (44.9) 1277 0.05* 9.2 49.2 29.2 9.2 3.3 0.006*
Yes 147 (55.1) 968 15 40.8 24.5 4.8 15.0
Child Overweight No 198 (74.2) 1152 0.23 9.1 45.0 28.3 8.1 9.6 0.05*
Yes 69 (25.8) 951 21.7 43.5 21.7 2.9 10.1
Child Atopy/Asthma Atopic Asthma 58 (21.7) 1412 0.08 12.1 41.4 36.2 0.0 10.3 0.28
Atopy Only 64 (24) 1065 0.82 17.2 46.9 20.3 7.8 7.8
Asthma Only 34 (12.7) 941 0.71 5.9 44.1 20.6 11.8 17.7
Healthy
5 111 (41.6) 1024 11.7 45.1 27.0 8.1 8.1
Anti-Inflammatory Meds
1 No 183 (68.5) 1047 0.30 13.1 42.6 8.2 26.8 9.3 0.10
Yes 84 (31.5) 1211 10.7 46.8 13.1 26.2 1.2
Mother Allergy/Asthma No 97 (36.3) 1225 0.24 13.4 39.2 25.8 9.3 12.4 0.43
Yes 167 (62.6) 1032 10.8 47.9 27.5 5.4 8.4
Annual Family Income ,$50,000 61 (22.9) 1182 0.35 19.7 49.2 14.8 6.6 9.8 0.16
,$80,000 89 (33.3) 1099 0.54 13.5 42.7 31.5 3.4 9.0
$$80,000
5 99 (37.1) 992 7.1 45.5 28.3 9.1 10.1
SES Trajectory Low 33 (12.4) 1994 0.02*
Mid
5 119 (44.6) 1174
Increasing 26 (9.7) 728 0.05*
Mid-High 71 (26.6) 935 0.18
High 18 (6.7) 787 0.16
Older Maternal Siblings No 111 (41.6) 1089 0.94 17.1 53.2 18 3.6 8.1 0.003*
Yes 153 (57.3) 1100 9.2 37.3 33.3 9.2 11.1
Birth Weight Normal 214 (80.2) 1119 0.68 11.7 47.2 24.3 7.9 8.9 0.21
Preterm or SGA 48 (18) 1038 14.6 35.4 35.4 2.1 12.5
Exclusive Breastfeeding
2 No 120 (44.9) 1112 0.94 15 44.2 26.7 5.8 8.3 0.75
Yes 145 (54.3) 1101 10.3 44.8 26.2 7.6 11
Mother Smoked
3 No 209 (78.3) 1097 1.00 10.5 46.4 29.2 5.7 8.1 0.05*
Yes 58 (21.7) 1096 19 37.9 17.2 10.3 15.5
Maternal Distress No 201 (75.3) 1059 0.41 9 44.8 29.9 6 10.5 0.08
Yes 57 (21.4) 1222 19.3 47.4 15.8 8.8 8.8
IL-6, interleukin-6; Geo. Mean, geometric mean; SES, socioeconomic status; SGA, small for gestational age.
IL-6 production induced by LPS treatment of PBMC.
1Anti-inflammatory medications used in the previous 12 months;
2Exclusive breastfeeding $3 months;
3Mother smoked during pregnancy and/or first year after birth;
4Log-transofrmed IL-6 values compared by t-test (2-groups) or univariate regression (3+ groups);
5reference group for multiple comparisons;
6SES distributions compared by chi-squared test;
*p,.05.
doi:10.1371/journal.pone.0038669.t002
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(787 pg/ml). These data clearly indicate the propensity of high-
SES children to exhibit more controlled immune activation upon
stimulation with a ubiquitous environmental stimulus.
Importantly, we found that children in the increasing-SES
trajectory group exhibited the lowest IL-6 responses (723 pg/ml),
at a value not statistically different from that of the highest SES
children. Thus, improving SES appears confer the same advan-
tages as being a member of the highest SES trajectory group from
birth. Current household income was not significantly associated
with intensity of IL-6 production (Table 2), highlighting the
advantage of using the more informative trajectory measure to
capture changes in SES over time.
In unadjusted analyses (Table 2), persistent low-SES was
associated with increased likelihood of FN ethnicity, overweight,
low current household income, being firstborn, relocating during
childhood, and having a mother who smoked or experienced
perinatal distress. IL-6 production was significantly increased in
urban children and tended to be higher in FN children and
children with atopic asthma. Early life factors (such as birth
weight, breastfeeding, and maternal smoking, distress and parity)
and anti-inflammatory medication use were not associated with
IL-6 production at age 9. Collectively, these findings demonstrate
that a number of potentially inter-related demographic factors,
including SES trajectories, are associated with the intensity of IL-6
production in school-aged children.
To determine the unique effects of SES trajectories on immune
capacity, we conducted multivariate regression analyses (Table 3).
The effect of SES trajectories on IL-6 production was found to be
independent of FN ethnicity, residence location, atopic asthma,
and family size. However, the SES trajectory/IL-6 association was
influenced by overweight status (p for interaction=0.08), such that
the highest IL-6 responses were observed among children who
were overweight and low-SES, while the lowest responses were
observed in normal weight, high-SES or increasing-SES children.
More specifically: among overweight children, the median level of
IL-6 production was 3.1-fold higher in those who were low-SES,
compared to their mid-SES counterparts (p=0.001), whereas low-
SES effects were non-significant in normal weight children (1.1-
fold difference, p=0.73). By contrast, the high- and increasing-
SES trajectories were associated with particularly low IL-6
production for normal weight children only (nearly 50% lower
than mid-SES children, p,0.05). As indicated above, these
comparisons were adjusted for FN ethnicity, residence location,
atopic asthma, and family size (Table 3, Model A).
We performed further model adjustment for early life factors
previously linked to innate immune activation: maternal parity,
breastfeeding, birth weight, and relocation during childhood [46–
49] (Table 3, Model B). Here, none were associated with IL-6
responses at age 9, nor did they significantly alter any of the
associations described above Adjustment for gender, anti-inflam-
matory medication use, maternal distress, and maternal smoking
also did not affect the results (data not shown). Notably, maternal
history of allergy/asthma intensified the observed SES trajectory
effects (p value for interaction=0.03, results not shown), such that
especially high IL-6 responses were elicited by low-SES,
overweight children with maternal allergy/asthma, while espe-
cially low responses were elicited by increasing-SES, normal
weight children without maternal allergy/asthma.
Additional predictors of immune responsiveness
Multivariate analysis further identified an association between
IL-6 production, residence location and atopic asthma (p for
interaction=0.03) – a notable finding given the extensive
literature on urban-rural differences in inflammatory disease
[34,35]. In urban centers, atopic asthma was associated with a
54% increase in the intensity of IL-6 production (p=0.03),
whereas atopic asthma was not associated with IL-6 production in
rural children (p=0.24). These associations were independent of
SES trajectories, overweight, and all other factors tested (Table 3,
Model B). Finally, given the disproportionately low SES of
Canadian FN in this region, and the increased prevalence of
inflammatory disorders in this population [51,52], we examined
whether there was an association between FN ethnicity and
immune capacity, independent of SES trajectories (Table 3).
Figure 1. Childhood SES trajectories. SES trajectories were derived
from parent-reported housing data (number of bedrooms in the family
home, for each year of the child’s life). Individual children were assigned
to trajectory groups using a semiparametric, group-based statistical
modeling strategy; the number of children in each group is shown.
Plotted lines represent the average trajectory for each group. SES,
socioeconomic status.
doi:10.1371/journal.pone.0038669.g001
Figure 2. IL-6 responses by SES trajectory group. IL-6 responses
were measured in LPS-stimulated PBMC by ELISA; children were
assigned to SES trajectory groups as depicted in Figure 1. Data points
represent individual children; bars represent geometric means. Log-
normalized values compared by ANOVA with post-testing for linear
trend and multiple comparisons. ELISA, enzyme-linked immunosorbent
assay; LPS, lipopolysachharide; PBMC, peripheral blood mononuclear
cells; SES, socioeconomic status.
doi:10.1371/journal.pone.0038669.g002
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compared to non-FN children, regardless of SES trajectories and
all other factors tested (p=0.02).
Discussion
In a cohort of 267 Canadian children born in 1995, we found
evidence of elevated innate immune responsiveness in schoolchil-
dren experiencing persistent low-SES since birth, consistent with
the hypothesis that early social inequalities impact physiologic
programming [1]. Our results are novel in several ways. First, we
performed our analyses in children, whereas previous research has
focused on clinical outcomes in adulthood. Second, we assessed
stimulated IL-6 responses, whereas most previous studies have
reported on circulating IL-6. Third, we found that the detrimental
effect of low SES on immune responsiveness is exacerbated by
overweight. Finally, and most importantly, by examining dynamic
SES trajectories we identified a clear difference in immune
responsiveness among those children who experienced increasing
SES during early life.
This is the first study to investigate the relationship between
dynamic SES trajectories and innate immune responsiveness in
children. Overall, we observed that children living continuously in
low SES environments had 70% higher IL-6 responses compared
to children in mid-SES households. This elevation may be
clinically significant, since equivalent increases in circulating IL-
6 (in healthy adults) have been shown to predict myocardial
infarction [53]. Previous studies have documented elevated IL-6 in
adults who experienced low early-life SES [13,54], but to date only
one such study has been conducted in children [41]. In that report,
Howe et al. reported socioeconomic inequalities in cardiovascular
risk factors (including IL-6) in 10-year-olds, but they assessed IL-6
in serum and used ‘‘snapshot’’ measures of SES, whereas we
measured immune responsiveness and characterized SES trajec-
tories throughout childhood.
Overweight was found to intensify SES differences in immune
capacity. Overweight, persistently low-SES children had 3-fold
higher IL-6 responses compared to their mid-SES counterparts.
Together with recent reports of overweight/SES interactions in
asthma [55] and cardiovascular health [41], this suggests that
overweight may play a preeminent role in moderating or
amplifying SES effects on immune responsiveness and ultimate
development of inflammatory disease. While additional research is
required to determine the biological pathways behind these
observations, our results point towards shared characteristics of
low-SES and overweight children as mediators of immune
responsiveness. For example, unhealthy diet and inactivity are
independently associated with both low SES and overweight [56],
and both can contribute to chronic inflammation [57,58]. We
therefore speculate that among low-SES children, those who are
overweight have especially poor nutrition and low physical
activity, resulting in especially elevated immune response profiles.
The potential for overweight and low-SES to act synergistically in
elevating immune responsiveness has considerable public health
implications, since overweight and obesity disproportionately
affect low SES populations [56].
Interestingly, the lowest intensity of inflammatory IL-6
responses occurred in children of the increasing-SES trajectory
group, who produced levels that were indistinguishable from
children at the highest SES level. They were also clearly distinct
from the mid-SES group, despite being born into a similar
socioeconomic environment. Consistent with evidence for the
detrimental influence of low SES during early life [30], and for a
protective role of social mobility during childhood [4], these
Table 3. Innate immune responsiveness at age 9 according to childhood SES trajectories and other factors: IL-6 response ratios
(95% CI).
Model A Model B
Child Overweight Normal Overweight Normal Overweight
SES Trajectory Group low 1.10 (0.63–1.92) 3.10 (1.57–6.14)** 1.10 (0.61–1.99) 3.11 (1.55–6.24)**
mid 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
mid-high 0.69 (0.48–1.00)* 0.94 (0.48–1.86) 0.63 (0.43–0.93)* 1.05 (0.51–2.13)
high 0.53 (0.29–0.96)* 1.93 (0.39–9.49) 0.46 (0.25–0.86)* 1.72 (0.33–8.96)
increasing 0.52 (0.30–0.90)* 1.21 (0.49–2.98) 0.46 (0.25–0.83)* 1.35 (0.54–3.37)
First Nations Ethnicity yes 1.51 (1.02–2.23)* 1.51 (1.02–2.23)* 1.62 (1.12–2.61)* 1.62 (1.12–2.61)*
no 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Residence/Atopic Asthma urban/yes 1.80 (1.20–2.72)** 1.80 (1.20–2.72)** 1.71 (1.12–2.61)* 1.71 (1.12–2.61)*
urban/no 1.14 (0.83–1.57) 1.14 (0.83–1.57) 1.11 (0.79–1.55) 1.11 (0.79–1.55)
rural/yes 0.77 (0.42–1.39) 0.77 (0.42–1.39) 0.69 (0.37–1.29) 0.69 (0.37–1.29)
rural/no 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Also Adjusted For: family size at age 9 family size at age 9, maternal
allergy/asthma, relocation
since birth, and early life
factors: breastfeeding, birth
weight, parity
SES, socioeconomic status; IL-6, interleukin 6.
Response ratios represent relative differences (ratios) of IL-6 responses compared to the appropriate referent (ref) category. For example, the value of 1.51 for First
Nations children in Model A indicates that IL-6 responses were 51% higher compared to non-First Nations children. A value of 1.00 indicates no difference in IL-6
responses; values less than 1.00 indicate lower IL-6 responses (e.g., 0.90 would indicate a value of 10% lower for the group in question).
*p,.05;
**p,.01.
doi:10.1371/journal.pone.0038669.t003
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to produce more favorable immune response profiles. Carroll et al.
recently reported that only very early SES (years 1–2 after birth)
predicts circulating IL-6 in adults, raising the possibility that there
may be a ‘‘critical window’’ in early childhood when SES
conditions have a greater impact on future inflammation [54]. By
investigating SES trajectories throughout childhood, our findings
suggest that upward SES mobility during later childhood can
potentially reverse the detrimental effects of low SES during this
‘‘critical window’’. Notably in our study, the protective effect of
increasing SES only applied to normal weight children.
Independent of SES trajectories, First Nations children were
found to have 51% higher IL-6 responses compared to non-FN
children. Since this association was also independent of over-
weight, and was found in FN children living both on and off
reserve, we speculate that other genetic, lifestyle or environmental
factors are responsible for the observed increase in IL-6 responses
[59]. Consistent with this thesis, studies have reported that
Canadian FN individuals have a higher frequency of single-
nucleotide polymorphisms favouring increased expression of the
IL-6 gene [43]. We add to this literature by presenting evidence
for actual differences in immune cell production of IL-6 between
Canadian FN and non-FN children.
This analysis also identifies another high risk group of children.
Compared to their rural counterparts, children with atopic asthma
in urban centers exhibited greater immune responsiveness. This
finding is significant since there is an established connection
between urban living and greater prevalence of inflammatory
diseases such as asthma and ulcerative colitis [34,35], but IL-6
differences according to residence location have not been widely
studied. Recently, Huttenen et al. demonstrated increased toxicity
and inflammatory responses in cultured macrophages exposed to
airborne particles collected at urban versus rural sites [60].
Consistent with this study, our results suggest that innate immune
activation (here, IL-6) could offer a biological marker of the
‘‘urban influence’’ on systemic inflammation, and the development
of asthma or other chronic disease. More work will be required to
test this hypothesis.
A major strength of this study was the determination in a large
sample of children, of stimulated IL-6 responses to assess immune
cell responsivity, rather than using a proxy measure of circulating
IL-6 levels. Published serum or plasma concentrations typically
range from ,1 pg/ml to 2 pg/ml, a narrow range that is very
close to the detection limit for most assays. Thus, many individuals
have undetectable levels and reported differences can be
challenging to interpret. In contrast, our ex vivo stimulation assay
uses environmental levels of an innate immune ligand to generate
reproducible IL-6 responses in every individual, with detectable
levels over a broad range (10–10,000 pg/mL) yielding meaningful
differences between subjects or groups. Our cohort included both
asthmatic and healthy children from urban and rural environ-
ments, and comprised a sizeable group of FN children. Since child
asthma status was accounted for in our analyses, the results can be
generalized to children with and without asthma despite the case-
control study design.
The major limitation of this study was that, in contrast to our
ability to measure trajectories of SES, we were confined to a single
determination of the IL-6 response at age 9. While one can
speculate that genetic and early life environmental factors (such as
family SES and residence location) preceded the development of
immune phenotypes, direct evidence for this requires longitudinal
immune studies over the first decade of life. Nevertheless, our
single measure of IL-6 response is highly reliable since measure-
ment error was controlled for by culturing PBMC in triplicate,
stimulating with physiologic levels of LPS, performing IL-6 assays
in duplicate, and utilizing standardized titration curves. Another
potential limitation of our study is selection bias, since children
without SES trajectory data were necessarily excluded. As shown
in Table 1, this restriction led to under-representation of rural and
overweight children and over-representation of children with
maternal allergy/asthma; however, these factors were adjusted for
in our multivariate analysis. More importantly, our main findings
would be unaffected by this potential bias since children with and
without SES trajectory data did not differ with respect to the main
exposure (SES, indicated by current household income) or
outcome (IL-6 production) of interest. While IL-6 responses,
overweight and child atopy/asthma were measured directly, other
variables were assessed by questionnaires, which are sensitive to
bias [61]. Our questionnaires were expertly designed to minimize
bias, and several of the measures have subsequently been validated
against medical records [28]. Notably, SES trajectories were based
on retrospective recall of housing data, which could create bias if
data were recalled differently by parents of children with high or
low immune responsiveness; however, this seems unlikely. Others
have shown that housing data tend to be accurately recalled [55],
and there is no reason to expect this accuracy to vary
systematically according to child immune responsiveness. Finally,
although we have tested a large number of potential covariates, we
cannot exclude the possibility that other factors (beyond the scope
of our analyses) may contribute to the pathway between SES
trajectories, immune responsiveness and subsequent health out-
comes.
In sum, using a novel strategy for investigating immune
responsiveness in conjunction with novel SES trajectory measures,
we discovered an association between chronic exposure to a low-
SES environment from birth and elevated IL-6 responses at age 9,
indicating excess innate immune activity and heightened risk for
disease. Collectively, these results suggest a role for global innate
immune activation in the well-established relationships between
SES and clinical outcomes. Most importantly from the knowledge
translation perspective, the data reveal a marked protective effect
among normal-weight children whose families improved their SES
during childhood. These findings provide experimental data in
support of recent appeals [62] for interventions aimed at
decreasing socioeconomic disparities during early childhood in
order to limit or reverse the detrimental effects of exposure to low
SES.
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